Skip to content

Protective effect of propofol pretreatment on myocardial ischemic reperfusion injury during CPB

Protective effect of propofol pretreatment on myocardial ischemic reperfusion injury during CPB

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ICC-15007000
Enrollment
Unknown
Registered
2015-08-30
Start date
2015-08-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myocardial ischemic reperfusion injury

Interventions

Group plopofol:Combination of propofol and Sevoflurane
Group Sevoflurane:Sevoflurane

Sponsors

Affiliated Hospital of Guangdong Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 60 volunteer patients, 20-70 years of age, NYHA grade II to III, ASA grade II to III, at a university hospital undergoing heart valve replacement.

Exclusion criteria

Exclusion criteria: 1. previous coronary or valvular heart surgery; 2. combined operations; 3. preoperative myocardial infarction within the last 4 weeks or ongoing myocardial infarction; 4. poor ventricular function (ejection fraction 0.30); 5. preoperative haemodynamic instability with the need for medical or mechanical support; 6. severe hepatic disease; 7. renal insufficiency; 8. severe chronic obstructive pulmonary disease [FEV1 (forced expiratory volume in1 s) <0. 5litres]; 9. severe coagulation abnormalities, and 10. history of neurological disturbances.

Design outcomes

Primary

MeasureTime frame
hemodynamics;cTnT;TNF-a;Endothelial microparticles;

Countries

China

Contacts

Public ContactLiang-qing zhang
zhanglq1970@163.com+86 13822586877

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026